These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6732778)

  • 1. Binding of 5-methoxypsoralen to human serum low density lipoproteins.
    Melo Tde S; Morlière P; Goldstein S; Santus R; Dubertret L; Lagrange D
    Biochem Biophys Res Commun; 1984 Apr; 120(2):670-6. PubMed ID: 6732778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of 8-methoxypsoralen by human serum albumin.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1978 Sep; 33(9):667-75. PubMed ID: 744263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro.
    Artuc M; Stuettgen G; Schalla W; Schaefer H; Gazith J
    Br J Dermatol; 1979 Dec; 101(6):669-77. PubMed ID: 534612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs.
    Bevilacqua R; Benassi CA; Schiavon O; Veronese FM
    Farmaco Sci; 1981 Jul; 36(7):598-605. PubMed ID: 7274442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
    Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
    Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins.
    Bonneau S; Vever-Bizet C; Morlière P; Mazière JC; Brault D
    Biophys J; 2002 Dec; 83(6):3470-81. PubMed ID: 12496113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dark interaction of 5-methoxypsoralen and 8-methoxypsoralen with erythrocyte ghosts: a fluorescence and circular dichroism study.
    Blais J; Milhaud J; Bolard J; Vigny P
    J Photochem Photobiol B; 1991 May; 9(2):161-70. PubMed ID: 1907648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
    Pibouin M; Zini R; Nguyen P; Renouard A; Tillement JP
    Br J Dermatol; 1987 Aug; 117(2):207-15. PubMed ID: 3651341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for uptake of 8-methoxypsoralen and 5-methoxypsoralen by cellular nuclei.
    Sasaki M; Meguro F; Kumazawa E; Fujita H; Kakishima H; Sakata T
    Mutat Res; 1988 Jan; 197(1):51-8. PubMed ID: 3336374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance thin-layer chromatographic determination of 5-methoxypsoralen in serum from patients.
    Mignot B; Guillaume Y; Makki S; Murret E; Cavalli E; Truong TT; Thomassin M; Guinchard C
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):283-5. PubMed ID: 9390742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of 5-methoxypsoralen in human serum.
    Wang LH; Tso M
    J Pharm Biomed Anal; 2002 Oct; 30(3):593-600. PubMed ID: 12367684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralen phototoxicity: correlation with serum and epidermal 8-methoxypsoralen and 5-methoxypsoralen in the guinea pig.
    Kornhauser A; Wamer WG; Giles AL
    Science; 1982 Aug; 217(4561):733-5. PubMed ID: 7100920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine concentrations of 5-methoxypsoralen after oral administration.
    Stolk LM; Westerhof W; Cormane RH; van Zwieten PA
    Br J Dermatol; 1981 Oct; 105(4):415-9. PubMed ID: 7295552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
    Wamer W; Giles A; Kornhauser A
    Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on mechanism of 8-methoxypsoralen-DNA interaction in the dark.
    Arabzadeh A; Bathaie SZ; Farsam H; Amanlou M; Saboury AA; Shockravi A; Moosavi-Movahedi AA
    Int J Pharm; 2002 Apr; 237(1-2):47-55. PubMed ID: 11955803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cytotoxicity of low-density lipoprotein to helper T cells of cutaneous T-cell lymphoma after photoperoxidation with 8-methoxypsoralen.
    Fossel ET; Fletcher JG; McDonagh J; Hui KK
    J Natl Cancer Inst; 1991 Sep; 83(18):1316-21. PubMed ID: 1832193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on the paper by V. Nitsche et al.: 8-Methoxypsoralen (8-MOP) in neuer galenischer Zubereitung und seine Beziehung zum 8-MOP-Serumspiegel. 8-Methoxypsoralen (8-MOP)--a new galenic form and its relation to 8-MOP serum levels.
    Siddiqui AH
    Arch Dermatol Res; 1982; 272(1-2):181. PubMed ID: 7165319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.